Baghdadi M - Search Results

1

Interleukin 34, from pathogenesis to clinical applications.

Baghdadi M, Endo H, Tanaka Y, Wada H, Seino KI. Baghdadi M, et al. Cytokine. 2017 Nov;99:139-147. doi: 10.1016/j.cyto.2017.08.020. Epub 2017 Sep 5. Cytokine. 2017. PMID: 28886491 Review.

2

High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers.

Baghdadi M, Endo H, Takano A, Ishikawa K, Kameda Y, Wada H, Miyagi Y, Yokose T, Ito H, Nakayama H, Daigo Y, Suzuki N, Seino KI. Baghdadi M, et al. Sci Rep. 2018 Jan 11;8(1):418. doi: 10.1038/s41598-017-18796-8. Sci Rep. 2018. PMID: 29323162 Free PMC article.

3

Interleukin-34, a comprehensive review.

Baghdadi M, Umeyama Y, Hama N, Kobayashi T, Han N, Wada H, Seino KI. Baghdadi M, et al. J Leukoc Biol. 2018 Nov;104(5):931-951. doi: 10.1002/JLB.MR1117-457R. Epub 2018 Aug 1. J Leukoc Biol. 2018. PMID: 30066957 Review.

4

Interleukin-34 expression in ovarian cancer: a possible correlation with disease progression.

Endo H, Hama N, Baghdadi M, Ishikawa K, Otsuka R, Wada H, Asano H, Endo D, Konno Y, Kato T, Watari H, Tozawa A, Suzuki N, Yokose T, Takano A, Kato H, Miyagi Y, Daigo Y, Seino KI. Endo H, et al. Among authors: baghdadi m. Int Immunol. 2020 Mar 7;32(3):175-186. doi: 10.1093/intimm/dxz074. Int Immunol. 2020. PMID: 31868884 Free article.

5

Blocking monoclonal antibodies of TIM proteins as orchestrators of anti-tumor immune response.

Baghdadi M, Takeuchi S, Wada H, Seino K. Baghdadi M, et al. MAbs. 2014;6(5):1124-32. doi: 10.4161/mabs.32107. Epub 2014 Oct 30. MAbs. 2014. PMID: 25517298 Free PMC article. Review.

6

Identification of a highly immunogenic mouse breast cancer sub cell line, 4T1-S.

Abe H, Wada H, Baghdadi M, Nakanishi S, Usui Y, Tsuchikawa T, Shichinohe T, Hirano S, Seino K. Abe H, et al. Among authors: baghdadi m. Hum Cell. 2016 Apr;29(2):58-66. doi: 10.1007/s13577-015-0127-1. Epub 2016 Feb 8. Hum Cell. 2016. PMID: 26857856 Free article.

7

Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells.

Baghdadi M, Wada H, Nakanishi S, Abe H, Han N, Putra WE, Endo D, Watari H, Sakuragi N, Hida Y, Kaga K, Miyagi Y, Yokose T, Takano A, Daigo Y, Seino KI. Baghdadi M, et al. Cancer Res. 2016 Oct 15;76(20):6030-6042. doi: 10.1158/0008-5472.CAN-16-1170. Epub 2016 Aug 22. Cancer Res. 2016. PMID: 27550451 Free article.

8

Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma.

Han N, Baghdadi M, Ishikawa K, Endo H, Kobayashi T, Wada H, Imafuku K, Hata H, Seino KI. Han N, et al. Among authors: baghdadi m. Inflamm Regen. 2018 Mar 5;38:3. doi: 10.1186/s41232-018-0060-2. eCollection 2018. Inflamm Regen. 2018. PMID: 29515691 Free PMC article.

9

Enhanced expression of IL-34 in an inflammatory cyst of the submandibular gland: a case report.

Baghdadi M, Ishikawa K, Endo H, Umeyama Y, Ataka T, Wada H, Oyamada Y, Hyakushima N, Seino KI. Baghdadi M, et al. Inflamm Regen. 2018 Jul 10;38:12. doi: 10.1186/s41232-018-0069-6. eCollection 2018. Inflamm Regen. 2018. PMID: 30002743 Free PMC article.

10

A role for IL-34 in osteolytic disease of multiple myeloma.

Baghdadi M, Ishikawa K, Nakanishi S, Murata T, Umeyama Y, Kobayashi T, Kameda Y, Endo H, Wada H, Bogen B, Yamamoto S, Yamaguchi K, Kasahara I, Iwasaki H, Takahata M, Ibata M, Takahashi S, Goto H, Teshima T, Seino KI. Baghdadi M, et al. Blood Adv. 2019 Feb 26;3(4):541-551. doi: 10.1182/bloodadvances.2018020008. Blood Adv. 2019. PMID: 30782613 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page